Document
IPR2024-00631, No. 1046 Exhibit - 1046 Yun, Pharmacokinetic and Pharmacodynamic Modelling of the Effects of G (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1046 Exhibit - 1046 Yun, Pharmacokinetic and Pharmacodynamic Modelling of the Effects of G (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1074 Exhibit - 1074 WO 0037098 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1074 Exhibit - 1074 WO 0037098 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1035 Exhibit - 1035 Lund, Emerging GLP1 Receptor Agonists, 16 EXPERT OP ON EMERGING DRUG (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1035 Exhibit - 1035 Lund, Emerging GLP1 Receptor Agonists, 16 EXPERT OP ON EMERGING DRUG (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2110 Exhibit - EX2110 Verges, B and Charbonnel, B, After the LEADER trial and SUSTAIN 6, how do we explain the cardiovascular benefits of some GLP 1 receptor agonis...
Cite Document
IPR2023-00724, No. 2110 Exhibit - EX2110 Verges, B and Charbonnel, B, After the LEADER trial and SUSTAIN 6, how do we explain the cardiovascular benefits of some GLP 1 receptor agonists Diabetes Met
+ More Snippets
Document
IPR2024-00107, No. 1095 Exhibit - Declaration of Alekha Dash, PhD (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1095 Exhibit - Declaration of Alekha Dash, PhD (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1014 Exhibit - Clinical Trial No NCT00851773 (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1014 Exhibit - Clinical Trial No NCT00851773 (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1026 Exhibit - HARRISON’S PRINCIPLES OF INTERNAL MED, Chapter 338 Fauci et al eds 17th (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1026 Exhibit - HARRISON’S PRINCIPLES OF INTERNAL MED, Chapter 338 Fauci et al eds 17th (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1085 Exhibit - ACS Publications, httpspubsacsorgtocjmcmar4717 httpspubsacso (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1085 Exhibit - ACS Publications, httpspubsacsorgtocjmcmar4717 httpspubsacso (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1096 Exhibit - CV of Alekha Dash, PhD (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1096 Exhibit - CV of Alekha Dash, PhD (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1003 Exhibit - Declaration of John Bantle, MD (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1003 Exhibit - Declaration of John Bantle, MD (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1063 Exhibit - Kirillova, Results and Outcome Reporting in ClinicalTrialsgov, What Makes (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1063 Exhibit - Kirillova, Results and Outcome Reporting in ClinicalTrialsgov, What Makes (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1047 Exhibit - Tamimi, Drug Development From Concept to Marketing, 113 NEPHRON CLINICAL (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1047 Exhibit - Tamimi, Drug Development From Concept to Marketing, 113 NEPHRON CLINICAL (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1049 Exhibit - International Conference on Harmonisation Dose Response Information to Sup (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1049 Exhibit - International Conference on Harmonisation Dose Response Information to Sup (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1028 Exhibit - Holst, Glucagon Like Peptide 1 and Inhibitors of Dipeptidyl Peptidase IV in (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1028 Exhibit - Holst, Glucagon Like Peptide 1 and Inhibitors of Dipeptidyl Peptidase IV in (P.T.A.B. Nov. 2, 2023)
+ More Snippets
Document
IPR2024-00107, No. 1092 Exhibit - CV of Melissa Weinberg, MD (P.T.A.B. Nov. 2, 2023)
Cite Document
IPR2024-00107, No. 1092 Exhibit - CV of Melissa Weinberg, MD (P.T.A.B. Nov. 2, 2023)
+ More Snippets